Recursion Pharmaceuticals Q1 2026 Earnings Narrowed Loss Beats Estimates Amid Pipeline Progress vTv Therapeutics Q1 2026 Earnings EPS Surges to 165 Far Above Estimates Despite No Reported Revenue EXK Q1 2026 Earnings EPS Smashes Estimates by Nearly 60 Stock Edges Lower FRO Q1 2026 Earnings EPS Beats Estimates by 572 as Stock Declines OTIS Q1 2026 Earnings EPS Falls Short of Estimates Amid Mixed Demand American Rebel Holdings Inc AREB Q1 2026 Earnings Significant Net Loss Amid Lack of Revenue